Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Simon Nieto

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Research|March 11, 2026
Targeting the Non-Homologous End-Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin by Enhancing p53-Mediated SenescenceThijs Jalving, Carine Dufau, Juan Simon Nieto, et al.
Journal for Immunotherapy of Cancer|November 7, 2024
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunctionDavid W Vredevoogd, Georgi Apriamashvili, Pierre L Levy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2024
Tumor-Secreted Extracellular Vesicles Counteract Therapy Response by Triggering Inflammatory Mesenchymal Stem Cell DevelopmentCrescenzo Massaro, Hilal N Sensoy, Manon Mulders, et al.
Nature|November 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samplesSofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Research|March 11, 2026
Targeting the Non-Homologous End-Joining Pathway Sensitizes MDM2-Amplified Liposarcoma to Doxorubicin by Enhancing p53-Mediated SenescenceThijs Jalving, Carine Dufau, Juan Simon Nieto, et al.
Journal for Immunotherapy of Cancer|November 7, 2024
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunctionDavid W Vredevoogd, Georgi Apriamashvili, Pierre L Levy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2024
Tumor-Secreted Extracellular Vesicles Counteract Therapy Response by Triggering Inflammatory Mesenchymal Stem Cell DevelopmentCrescenzo Massaro, Hilal N Sensoy, Manon Mulders, et al.
Nature|November 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samplesSofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto, et al.
Pageof 1